(Q45710516)

15 December 2017

title

Evaluation of a line probe assay for identification of hepatitis B virus precore variants in serum from chronic hepatitis B carriers (English)

1 reference

15 December 2017

1 reference

1 reference

Peter Muir

2

1 reference

15 December 2017

Sally Corden

4

1 reference

15 December 2017

Erwin Sablon

6

1 reference

15 December 2017

Lieven Stuyver

7

1 reference

15 December 2017

Charlotte L. Cameron-Wilson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14599684

28 March 2024

Anna L. Ballard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14599684

28 March 2024

Elizabeth H. Boxall

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14599684

28 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14599684

28 March 2024

publication date

1 December 2003

1 reference

full work available at URL

15 December 2017

https://api.elsevier.com/content/article/PII:S0166093403002982?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

https://api.elsevier.com/content/article/PII:S0166093403002982?httpAccept=text/plain

28 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

Journal of Virological Methods

28 March 2024

published in

1 reference

15 December 2017

volume

114

1 reference

15 December 2017

issue

1

1 reference

15 December 2017

page(s)

97-103

1 reference

Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure

15 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

Colourimetric point mutation assay: for detection of precore mutants of hepatitis B.

28 March 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

Assessing the infectivity of hepatitis B carriers

28 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

Epidemiology of precore mutants of hepatitis B in the United Kingdom

28 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication

28 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

The e antigen and vertical transmission of hepatitis B surface antigen

28 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

A novel assay for hepatitis B e markers

28 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B.

28 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication

28 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

28 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

New method for the extraction of viral RNA and DNA from cerebrospinal fluid for use in the polymerase chain reaction assay

28 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

HBV core promoter mutations prevail in patients with hepatocellular carcinoma from Guangxi, China

28 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity

28 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease.

28 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

Novel application of a point mutation assay: evidence for transmission of hepatitis B viruses with precore mutations and their detection in infants with fulminant hepatitis B

28 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

The core promoter of hepatitis B virus

28 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen-negative patients

28 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

Naturally occurring hepatitis B virus mutants with deletions in the core promoter region

28 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

Hepatitis B virus core promoter sequence analysis in fulminant and chronic hepatitis B.

28 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal

28 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

A new antigen complex co-occurring with Australia antigen

28 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

Selection for a pre-C stop codon mutation in a hepatitis B virus variant with a pre-C initiation codon mutation during interferon treatment

28 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

28 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene

28 March 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

Three cases of severe subfulminant hepatitis in heart-transplanted patients after nosocomial transmission of a mutant hepatitis B virus

28 March 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen

28 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.JVIROMET.2003.09.014

28 March 2024

Identifiers

1 reference

15 December 2017

1 reference